November 13, 2017-ROCHESTER, NY-Bio-Optronics, the makers of the Clinical Conductor Clinical Trial Management System (CTMS), and Complion, the eRegulatory and document management platform for sites, have partnered to integrate their best-in-class solutions to deliver a solution for research organizations.
The companies are building upon their long-standing commitment to meet customer needs and develop innovative solutions to empower investigative sites to run the world’s research. This integration introduces a robust application suite, enabling research organizations to operate efficiently and profitably, while maintaining compliance with 21 CFR Part 11, HIPAA, and Good Clinical Practice (GCP).
Clinical research sites receive the most advanced tools for study management through Clinical Conductor-including finances, recruitment, and participant management-with the added power from Complion for regulatory and document management. By streamlining access to critical study documents and statuses, sites can reduce bottlenecks, improve efficiency, and facilitate more timely and accurate decisions.
“We wanted to partner with the best eRegulatory provider in the business to provide the industry with unparalleled innovations that further complement our powerful CTMS and allow research businesses to maximize their operations and enhance research quality,” said Steve Bailey, VP of Clinical Conductor CTMS.
“Complion’s best-in-class regulatory and document management platform complements the multi-tiered robustness of Clinical Conductor CTMS. This integration is a natural extension as it provides a fuller solution for sites. Our partnership provides a step forward for our joint customers and we look forward to collaborating with Bio-Optronics to support investigative sites and advance research,” said Rick Arlow, Founder and CEO of Complion.
Other integrations from Bio-Optronics have included a multitude of software applications such as EMR, EDC, ePRO. The latest integration with Complion is available now, and all are invited to learn more at MAGI West 2017.
About Complion
Complion’s regulatory and document management platform simplifies the management of trial documentation to ensure site efficiency and improve regulatory compliance. Complion partners with physicians, Health Systems, Academic Medical Centers, and NCI designated Cancer Centers to define institutional standards and streamline research operations.
For more information, please visit http://www.complion.com/ or follow @Complion on Twitter or LinkedIn.
About Bio-Optronics
Bio-Optronics, the creator of Clinical Conductor CTMS, is a software and services company that creates user-focused software and services for healthcare organizations that positively impacts the lives of patients around the world. Clinical Conductor CTMS is an established clinical trial management system designed to help businesses run the world’s research. Utilized by thousands of research organizations worldwide, Clinical Conductor is designed to simplify and standardize complex research processes for businesses managing and conducting clinical trials.
For more information, visit www.bio-optronics.com or follow @BioOptronics on Twitter or LinkedIn.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.